F. Horaud
About
In The Last Decade
F. Horaud
32 papers receiving 495 citations
Peers
Comparison fields: 5 of 46
- Cardiology and Cardiovascular Medicine 380
- Infectious Diseases 274
- Molecular Biology 181
- Plant Science 81
- Animal Science and Zoology 79
Countries citing papers authored by F. Horaud
This map shows the geographic impact of F. Horaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Horaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Horaud more than expected).
Fields of papers citing papers by F. Horaud
This network shows the impact of papers produced by F. Horaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Horaud. The network helps show where F. Horaud may publish in the future.
Co-authorship network of co-authors of F. Horaud
This figure shows the co-authorship network connecting the top 25 collaborators of F. Horaud. A scholar is included among the top collaborators of F. Horaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Horaud. F. Horaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Viral safety of biological products and the concept of validation. | 1 |
| 2 | 16 | |
| 3 | 8 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 34 | |
| 7 | 3 | |
| 8 | Biologicals: an attempt at classification and its implication for the viral safety of products. | 1 |
| 9 | Absence of viral sequences in the WHO-Vero Cell Bank. A collaborative study. | 16 |
| 10 | 11 | |
| 11 | 15 | |
| 12 | 39 | |
| 13 | 2 | |
| 14 | 9 | |
| 15 | 3 | |
| 16 | Identification and characterization of a continuous neutralization epitope (C3) present on type 1 poliovirus. | 28 |
| 17 | 109 | |
| 18 | A rabies vaccine produced in a non-tumorigenic rabbit cell line. | 1 |
| 19 | Neutralization epitope patterns of poliovirus strains isolated from paralytic cases. | 4 |
| 20 | Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.